F545-2056 Screening compound: 4-methyl-N-(2-methyl-1-{3-[3-(pyrrolidine-1-carbonyl)phenyl]-1,2,4-oxadiazol-5-yl}propyl)benzene-1-sulfonamide

F545-2056 Screening compound: 4-methyl-N-(2-methyl-1-{3-[3-(pyrrolidine-1-carbonyl)phenyl]-1,2,4-oxadiazol-5-yl}propyl)benzene-1-sulfonamide
F545-2056 Screening compound: 4-methyl-N-(2-methyl-1-{3-[3-(pyrrolidine-1-carbonyl)phenyl]-1,2,4-oxadiazol-5-yl}propyl)benzene-1-sulfonamide alternative view

Chemical Structure Depiction of ChemDiv screening compound F545-2056
4-methyl-N-(2-methyl-1-{3-[3-(pyrrolidine-1-carbonyl)phenyl]-1,2,4-oxadiazol-5-yl}propyl)benzene-1-sulfonamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F545-2056

Molecular Formula

C24H28N4O4S (C24 H28 N4 O4 S)

Compound Name

4-methyl-N-(2-methyl-1-{3-[3-(pyrrolidine-1-carbonyl)phenyl]-1,2,4-oxadiazol-5-yl}propyl)benzene-1-sulfonamide

IUPAC name

4-methyl-N-(2-methyl-1-{3-[3-(pyrrolidine-1-carbonyl)phenyl]-124-oxadiazol-5-yl}propyl)benzene-1-sulfonamide

SMILES

CC(C)C(c1nc(-c2cc(C(N3CCCC3)=O)ccc2)no1)NS(c1ccc(C)cc1)(=O)=O

InChI

InChI=1S/C24H28N4O4S/c1-16(2)21(27-33(30,31)20-11-9-17(3)10-12-20)23-25-22(26-32-23)18-7-6-8-19(15-18)24(29)28-13-4-5-14-28/h6-12,15-16,21,27H,4-5,13-14H2,1-3H3/t21-/m0/s1

InChI Key

KNKMEFJXUFGDJQ-NRFANRHFSA-N

MDL Number (MFCD)

MFCD27175530

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

468.58

Hydrogen Bond Acceptors Count

10.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

4.813

Distribution Coefficient, logD

4.734

Water Solubility, LogSw

-4.56

Polar Surface Area

90.254

Acid Dissociation Constant (pKa)

8.10

Base Dissociation Constant (pKb)

-4.66

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

37.50

F545-2056 in Drug Discovery

Included in Screening Libraries

Antiviral Library (67538 compounds)

Protein Kinases Inhibitors Library (36801 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
Targets:
  • Kinases
  • Proteases

References: we are preparing a list of scientific research reports with F545-2056 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F545-2056?
Check Price and Availability of F545-2056, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F545-2056 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F545-2056
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F545-2056
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F545-2056 available by request